PAHC

Phibro Animal Health Corporation
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$1.40B
P/E Ratio
14.18
EPS
$2.43
Beta
0.47
52W High
$59.64
52W Low
$28.04
50-Day MA
$35.56
200-Day MA
$41.44
Dividend Yield
1.41%
Profit Margin
6.57%
Forward P/E
13.83
PEG Ratio
1.68

About Phibro Animal Health Corporation

Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.

Official WebsiteUSAFY End: June

Fundamentals

Revenue (TTM)$1.52B
Gross Profit (TTM)$505.97M
EBITDA$244.23M
Operating Margin10.60%
Return on Equity29.70%
Return on Assets8.48%
Revenue/Share (TTM)$37.44
Book Value$9.50
Price-to-Book3.59
Price-to-Sales (TTM)0.92
EV/Revenue1.378
EV/EBITDA8.98
Quarterly Earnings Growth (YoY)24.60%
Quarterly Revenue Growth (YoY)4.80%
Shares Outstanding$21.11M
Float$20.91M
% Insiders0.87%
% Institutions103.98%

Historical Volatility

HV 10-Day
27.33%
HV 20-Day
34.18%
HV 30-Day
32.04%
HV 60-Day
32.04%
HV Rank
11.5%

Volatility is currently contracting

Analyst Ratings

Consensus ($44.00 target)
1
Strong Buy
3
Hold
1
Strong Sell

Latest News

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research9/18/2026Positive
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference. President & Chief Executive Officer, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Tuesday, September 15, 2026, at 1:05 PM ET at New York Marriott Marquis in New York. The live audio presentation will be available on the.

Business Wire9/9/2026Neutral
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 2025) – Net sales of $396.7 million, an increase of $18.1 million, or 5% – Net income of $21.7 million, an increase of $4.5.

Business Wire8/26/2026Neutral
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2026 financial results on Wednesday, August 26, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 27, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab.

Business Wire8/19/2026Neutral
PAHC vs. SYK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research7/27/2026Positive
PAHC or LZAGY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Lonza Group Ag (LZAGY). But which of these two stocks is more attractive to value investors?

Zacks Investment Research7/9/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PAHC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/28/2026